Basic Information
NCLi provides end-to-end CDMO services in the cell and gene therapy field, including two core segments: CDO (Contract Development Services): process development for cell and gene therapies, and CMO (Contract Manufacturing Services): manufacturing services for cell and gene therapies. The company owns one of the largest CDMO production facilities in Japan and has established an exclusive partnership with Lonza, a global CDMO leader, to jointly advance the manufacturing business of cell and gene therapies in Japan. NCLi is a wholly-owned subsidiary of Nikon.
Nikon CeLL innovation Co., Ltd.
Tokyo,Tokyo,Japan
unclear
May 07, 2015
--

